FDA Inspection 1275180 — Columbus Center for Reproductive Endocrinology & Infertility, LLC

Columbus Center for Reproductive Endocrinology & Infertility, LLC — FEI 3005144073

The FDA completed an inspection of Columbus Center for Reproductive Endocrinology & Infertility, LLC on July 2, 2025 in Columbus, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 2, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Columbus, GA (United States)

Citations

IDCFRDescription
1224221 CFR 1271.55(c)Name and personal info on accompanying records